The similarity of the EGFR:MET transcript ratio in DFCI202 to those of our other MET-dependent models suggested that DFCI202 could represent an additional EGFR-mutant, MET-amplified NSCLC model sensitive to single-agent MET inhibition. This evidence concerns the gene MET and non-small cell lung carcinoma.